HINOVA
Live / Applied — Second extension granted (statement of use) (as of 29 Mar 2026)
What this means for you
Not registered yet, but its 18 Jan 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98364705
- Mark type
- Design + words
- Filed
- 18 Jan 2024
- Published for opposition
- 04 Feb 2025
- Attorney of record
- Frank Gao
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, pharmaceutical preparations and pharmaceutical products for treatment of cancers, hyperuricemia associated disorders and conditions, immune disorders and conditions, neural disorders, metabolic disorders, viral infections, cardiovascular disorders and conditions, and skin disorder and conditions
- Class 010 — Medical apparatus: Medical devices, namely, devices for diagnosis and treatment of cancers, hyperuricemia associated disorders and conditions, immune disorder and conditions, neural disorders, metabolic disorders, viral infections, cardiovascular disorders and conditions, and skin disorder and conditions
Owner
- Hinova Pharmaceuticals Inc., Chengdu, Sichuan, CN
- Hinova Pharmaceuticals Inc., Chengdu, Sichuan, CN
Prosecution history
- 29 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Mar 2026 — SOU EXTENSION 2 GRANTED
- 28 Mar 2026 — SOU EXTENSION 2 FILED
- 28 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 02 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Oct 2025 — SOU EXTENSION 1 GRANTED
- 01 Oct 2025 — SOU EXTENSION 1 FILED
- 01 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 01 Apr 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 04 Feb 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 04 Feb 2025 — PUBLISHED FOR OPPOSITION
- 29 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Jan 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Jan 2025 — EXAMINER'S AMENDMENT ENTERED
- 10 Jan 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED